Related Experiment Video
Updated: May 24, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A strategic framework for managing gestational diabetes in Mexico
Luis Alberto Martinez-Juarez1,2, Héctor Gallardo-Rincón3, Rodrigo Saucedo-Martínez4
1Johns Hopkins Center for Humanitarian Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.
Gestational Diabetes (GDM) is a prevalent health challenge in Mexico, affecting 10-14% of pregnancies but detected in only about 5.1% of cases, highlighting a critical gap in the healthcare system. This underdiagnosis poses severe health risks to mothers and children and reflects broader systemic healthcare failures. The disparity in detection rates points to insufficient screening protocols and uneven access to care, particularly affecting rural areas. Additionally, a lack of integrated digital health solutions exacerbates these issues, leading to inconsistent management and follow-up of diagnosed cases. The current reactive healthcare policies fail to prioritize early intervention and comprehensive patient education, crucial for effective GDM management. This paper calls for immediate and coordinated policy action to standardize GDM screening using updated protocols across all healthcare settings, bolster digital health infrastructure for better surveillance and management, and launch an extensive public health campaign focused on GDM awareness and education. These measures should be rigorously evaluated and adapted based on ongoing research and feedback to ensure they meet the needs of all segments of the population. Addressing these challenges head-on will improve health outcomes for mothers and children and reduce long-term healthcare costs associated with GDM complications.
Gestational Diabetes (GDM) is a prevalent health challenge in Mexico, affecting 10-14% of pregnancies but detected in only about 5.1% of cases, highlighting a critical gap in the healthcare system. This underdiagnosis poses severe health risks to mothers and children and reflects broader systemic healthcare failures. The disparity in detection rates points to insufficient screening protocols and uneven access to care, particularly affecting rural areas. Additionally, a lack of integrated digital health solutions exacerbates these issues, leading to inconsistent management and follow-up of diagnosed cases. The current reactive healthcare policies fail to prioritize early intervention and comprehensive patient education, crucial for effective GDM management. This paper calls for immediate and coordinated policy action to standardize GDM screening using updated protocols across all healthcare settings, bolster digital health infrastructure for better surveillance and management, and launch an extensive public health campaign focused on GDM awareness and education. These measures should be rigorously evaluated and adapted based on ongoing research and feedback to ensure they meet the needs of all segments of the population. Addressing these challenges head-on will improve health outcomes for mothers and children and reduce long-term healthcare costs associated with GDM complications.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: Biguanides and Glitazones

